Transcription Factors Sp1 and Sp3 Regulate Expression of Human ABCG2 Gene and Chemoresistance Phenotype

Overview

Journal Mol Cells

Publisher Elsevier

Specialties Cell Biology
Molecular Biology

Date 2013 Sep 3

PMID 23996530

Citations 23

Authors

Wook-Jin Yang

Min-Ji Song

Eun Young Park

Jong-Joo Lee

Joo-Hong Park

Keunhee Park

Jong Hoon Park

Hyoung-Pyo Kim

Affiliations

Soon will be listed here.

Abstract

ABCG2 is a member of the ATP binding cassette (ABC) transmembrane proteins that plays an important role in stem cell biology and drug resistance of cancer cells. In this study, we investigated how expression of human ABCG2 gene is regulated in lung cancer A549 cells. Binding of Sp1 and Sp3 transcription factors to the ABCG2 promoter in vitro and in vivo was elucidated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay. The ABCG2 promoter activity was impaired when Sp1 sites were mutated but was enhanced by overexpression of Sp1 or Sp3 proteins. Knockdown of Sp1 or Sp3 expression by short interfering RNA significantly decreased the expression of ABCG2 mRNA and protein, resulting in attenuated formation of the side population in A549 cells. In addition, Sp1 inhibition in vivo by mithramycin A suppressed the percentage of the side population fraction and sphere forming activities of A549 cells. Moreover, inhibiting Sp1- or Sp3-dependent ABCG2 expression caused chemosensitization to the anticancer drug cisplatin. Collectively, our results demonstrate that Sp1 and Sp3 transcription factors are the primary determinants for activating basal transcription of the ABCG2 gene and play an important role in maintaining the side population phenotype of lung cancer cells.

Citing Articles

Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer.

Chan S, Yeo C, Hong B, Tan E, Beh C, Yeo E Exp Hematol Oncol. 2025; 14(1):5.

PMID: 39800760 PMC: 11727331. DOI: 10.1186/s40164-024-00590-8.

SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells.

Tian P, Du D, Yang L, Zhou N, Tao L PLoS One. 2024; 19(2):e0298295.

PMID: 38354174 PMC: 10866488. DOI: 10.1371/journal.pone.0298295.

Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.

Chandratre S, Olsen J, Howley R, Chen B Biochem Pharmacol. 2023; 217:115851.

PMID: 37858868 PMC: 10842008. DOI: 10.1016/j.bcp.2023.115851.

Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer.

Bharathiraja P, Yadav P, Sajid A, Ambudkar S, Prasad N Drug Resist Updat. 2023; 71:101004.

PMID: 37660590 PMC: 10840887. DOI: 10.1016/j.drup.2023.101004.

Clinical relevance of stem cells in lung cancer.

Romeo H, Arcos M World J Stem Cells. 2023; 15(6):576-588.

PMID: 37424954 PMC: 10324501. DOI: 10.4252/wjsc.v15.i6.576.

References

Fischer B, Frei C, Moura U, Stahel R, Felley-Bosco E . Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer. 2012; 78(1):23-9. DOI: 10.1016/j.lungcan.2012.07.005. View

To K, Robey R, Knutsen T, Zhan Z, Ried T, Bates S . Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther. 2009; 8(10):2959-68. PMC: 3680354. DOI: 10.1158/1535-7163.MCT-09-0292. View

Chen Y, Huang W, Wei Y, Hsu S, Yuan P, Lin H . Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS One. 2011; 6(6):e21428. PMC: 3121773. DOI: 10.1371/journal.pone.0021428. View

Zhou S, Schuetz J, Bunting K, Colapietro A, Sampath J, Morris J . The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001; 7(9):1028-34. DOI: 10.1038/nm0901-1028. View

Dalerba P, Cho R, Clarke M . Cancer stem cells: models and concepts. Annu Rev Med. 2006; 58:267-84. DOI: 10.1146/annurev.med.58.062105.204854. View

Szatmari I, Vamosi G, Brazda P, Balint B, Benko S, Szeles L . Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem. 2006; 281(33):23812-23. DOI: 10.1074/jbc.M604890200. View

Hamada S, Satoh K, Hirota M, Kanno A, Umino J, Ito H . The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. J Cell Physiol. 2011; 227(2):729-38. DOI: 10.1002/jcp.22781. View

Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong J . Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res. 2012; 72(16):4178-92. PMC: 6261440. DOI: 10.1158/0008-5472.CAN-11-3983. View

To K, Polgar O, Huff L, Morisaki K, Bates S . Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res. 2008; 6(1):151-64. PMC: 3306834. DOI: 10.1158/1541-7786.MCR-07-0175. View

10.

Wang F, Xue X, Wei J, An Y, Yao J, Cai H . hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer. 2010; 103(4):567-74. PMC: 2939772. DOI: 10.1038/sj.bjc.6605724. View

11.

Mo W, Zhang J . Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol. 2012; 3(1):1-27. PMC: 3325772. View

12.

Allikmets R, Schriml L, Hutchinson A, Romano-Spica V, Dean M . A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998; 58(23):5337-9. View

13.

Krishnamurthy P, Ross D, Nakanishi T, Bailey-Dell K, Zhou S, Mercer K . The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem. 2004; 279(23):24218-25. DOI: 10.1074/jbc.M313599200. View

14.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B . Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999; 59(1):8-13. View

15.

Doyle L, Yang W, Abruzzo L, Krogmann T, Gao Y, Rishi A . A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998; 95(26):15665-70. PMC: 28101. DOI: 10.1073/pnas.95.26.15665. View

16.

Safe S, Abdelrahim M . Sp transcription factor family and its role in cancer. Eur J Cancer. 2005; 41(16):2438-48. DOI: 10.1016/j.ejca.2005.08.006. View

17.

Ho M, Ng A, Lam S, Hung J . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67(10):4827-33. DOI: 10.1158/0008-5472.CAN-06-3557. View

18.

Goodell M, McKinney-Freeman S, Camargo F . Isolation and characterization of side population cells. Methods Mol Biol. 2004; 290:343-52. DOI: 10.1385/1-59259-838-2:343. View

19.

Hassel B, Doyle L, Ross D . Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta. 2001; 1520(3):234-41. DOI: 10.1016/s0167-4781(01)00270-6. View

20.

Ee P, Kamalakaran S, Tonetti D, He X, Ross D, Beck W . Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 2004; 64(4):1247-51. DOI: 10.1158/0008-5472.can-03-3583. View